These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24125485)

  • 1. Phase II clinical trial of whole-brain irradiation plus three-dimensional conformal boost with concurrent topotecan for brain metastases from lung cancer.
    Ge XH; Lin Q; Ren XC; Liu YE; Chen XJ; Wang DY; Wang YQ; Cao B; Li ZG; Liu ML
    Radiat Oncol; 2013 Oct; 8():238. PubMed ID: 24125485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
    Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
    Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase III trial of topotecan and whole brain radiation therapy for patients with CNS-metastases due to lung cancer.
    Neuhaus T; Ko Y; Muller RP; Grabenbauer GG; Hedde JP; Schueller H; Kocher M; Stier S; Fietkau R
    Br J Cancer; 2009 Jan; 100(2):291-7. PubMed ID: 19127261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome of tyrosine kinase inhibitors alone or combined with radiotherapy for brain metastases from epidermal growth factor receptor (EGFR) mutant non small cell lung cancer (NSCLC).
    Zhu Q; Sun Y; Cui Y; Ye K; Yang C; Yang D; Ma J; Liu X; Yu J; Ge H
    Oncotarget; 2017 Feb; 8(8):13304-13311. PubMed ID: 28076323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Icotinib versus whole-brain irradiation in patients with EGFR-mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial.
    Yang JJ; Zhou C; Huang Y; Feng J; Lu S; Song Y; Huang C; Wu G; Zhang L; Cheng Y; Hu C; Chen G; Zhang L; Liu X; Yan HH; Tan FL; Zhong W; Wu YL
    Lancet Respir Med; 2017 Sep; 5(9):707-716. PubMed ID: 28734822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy with concurrent brain and thoracic radiotherapy in brain-only metastases of treatment naive small-cell lung cancer: a phase II study.
    Chen LK; Huang H; Liao H; Liu GZ; Zeng YD; Dinglin XX; Xu GC; Wei WD
    Med Oncol; 2012 Sep; 29(3):1687-92. PubMed ID: 21853344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of prophylactic cranial irradiation timing on brain relapse rates in patients with stage IIIB non-small-cell lung carcinoma treated with two different chemoradiotherapy regimens.
    Topkan E; Parlak C; Kotek A; Yuksel O; Cengiz M; Ozsahin M; Pehlivan B
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1264-71. PubMed ID: 22172902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival in patients with non-small cell lung cancer and synchronous brain metastasis treated with whole-brain radiotherapy and thoracic chemoradiation.
    Arrieta O; Villarreal-Garza C; Zamora J; Blake-Cerda M; de la Mata MD; Zavala DG; Muñiz-Hernández S; de la Garza J
    Radiat Oncol; 2011 Nov; 6():166. PubMed ID: 22118497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of brain metastasis from non-small cell lung cancer with whole brain radiotherapy and Gefitinib in a Chinese population.
    Ma S; Xu Y; Deng Q; Yu X
    Lung Cancer; 2009 Aug; 65(2):198-203. PubMed ID: 19091441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of intensive chemotherapy followed by reduced-dose and reduced-field irradiation for intracranial germ cell tumor.
    Takada A; Ii N; Hirayama M; Toyoda H; Matsubara T; Toyomasu Y; Kawamura T; Daimon T; Sakuma H; Nomoto Y
    J Neurosurg Pediatr; 2019 Mar; 23(3):317-324. PubMed ID: 30497152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and roles of combining temozolomide with whole brain radiotherapy in protection neurocognitive function and improvement quality of life of non-small-cell lung cancer patients with brain metastases.
    Deng X; Zheng Z; Lin B; Su H; Chen H; Fei S; Fei Z; Zhao L; Jin X; Xie CY
    BMC Cancer; 2017 Jan; 17(1):42. PubMed ID: 28068937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent irradiation with the anti-programmed cell death ligand-1 immune checkpoint blocker durvalumab: Single centre subset analysis from a phase 1/2 trial.
    Levy A; Massard C; Soria JC; Deutsch E
    Eur J Cancer; 2016 Nov; 68():156-162. PubMed ID: 27764686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy for brain metastases from small cell lung cancer.
    Reveiz L; Rueda JR; Cardona AF
    Cochrane Database Syst Rev; 2012 Jun; 2012(6):CD007464. PubMed ID: 22696370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-brain radiation therapy plus concomitant temozolomide for the treatment of brain metastases from non-small-cell lung cancer: a randomized, open-label phase II study.
    Chua D; Krzakowski M; Chouaid C; Pallotta MG; Martinez JI; Gottfried M; Curran W; Throuvalas N
    Clin Lung Cancer; 2010 May; 11(3):176-81. PubMed ID: 20439193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pemetrexed and cisplatin combination with concurrent whole brain radiotherapy in patients with brain metastases of lung adenocarcinoma: a single-arm phase II clinical trial.
    Dinglin XX; Huang Y; Liu H; Zeng YD; Hou X; Chen LK
    J Neurooncol; 2013 May; 112(3):461-6. PubMed ID: 23420398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent chemoradiotherapy with weekly nedaplatin versus radiotherapy alone in elderly patients with non-small-cell lung cancer.
    Chen F; Hu P; Liang N; Xie J; Yu S; Tian T; Zhang J; Deng G; Zhang J
    Clin Transl Oncol; 2018 Mar; 20(3):294-301. PubMed ID: 28741074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic effects and prognostic factors for the limited-stage small cell lung cancer treated with multidisciplinary therapy].
    Dong XJ; Wang MZ; Zhong W; Zhang L; Zhang XT; Zhao J; Xia Y; Li LY
    Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):216-21. PubMed ID: 22780978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer.
    Welsh JW; Komaki R; Amini A; Munsell MF; Unger W; Allen PK; Chang JY; Wefel JS; McGovern SL; Garland LL; Chen SS; Holt J; Liao Z; Brown P; Sulman E; Heymach JV; Kim ES; Stea B
    J Clin Oncol; 2013 Mar; 31(7):895-902. PubMed ID: 23341526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Three-dimensional conformal hypofractionated radiotherapy for brain metastases of non-small-cell lung carcinoma: implications for whole brain irradiation].
    Qiu XS; Chen LH; Chen YQ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov; 25(11):1375-8. PubMed ID: 16305959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in locally advanced non-small-cell lung cancer: a feasibility study.
    Liu YE; Lin Q; Meng FJ; Chen XJ; Ren XC; Cao B; Wang N; Zong J; Peng Y; Ku YJ; Chen Y
    Radiat Oncol; 2013 Aug; 8(1):198. PubMed ID: 23937855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.